Characterization of a novel germline BRCA1 splice variant, c.5332+4delA

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-017-4595-8PMID 29185120PMCID PMC6788766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients

  2017cited by this paper
• A Novel Germline Mutation in BRCA1 Causes Exon 20 Skipping in a Korean Family with a History of Breast Cancer

  2017cited by this paper
• Lessons from non-canonical splicing

  2016cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic

  2015cited by this paper
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer

  2014cited by this paper
• Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?

  2014cited by this paper
• Functional characterization of BRCA1 gene variants by mini-gene splicing assay

  2014cited by this paper
• Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics

  2014cited by this paper
• Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.

  2014cited by this paper
• Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations

  2013cited by this paper
• Pick one, but be quick: 5' splice sites and the problems of too many choices.

  2013cited by this paper
• Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

  2013cited by this paper
• BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer.

  2012cited by this paper
• ENIGMA—Evidence‐based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

  2012cited by this paper
• A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer

  2011cited by this paper
• Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

  2010cited by this paper
• BRCA1/2 mutations and triple negative breast cancers.

  2010cited by this paper
• BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer

  2009cited by this paper
• Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer

  2009cited by this paper
• Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance

  2008cited by this paper
• The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified

  2008cited by this paper
• Splicing in action: assessing disease causing sequence changes

  2005cited by this paper
• The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair

  2005cited by this paper
• Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain.

  2004cited by this paper
• Emerging roles of BRCA1 alternative splicing

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.

  2002cited by this paper
• Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1

  2001cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• …Functional motifs…

  1996cited by this paper
• BRCA1 protein products ... Functional motifs...

  1996cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper

• Value of the loss of heterozygosity to BRCA1 variant classification

  2022cites this paper
• Value of the loss of heterozygosity to BRCA1 variant classification

  2022cites this paper
• Somatic data usage for classification of germ line variants

  2021cites this paper
• BRCA1-No Matter How You Splice It.

  2019cites this paper
• Novel bioinformatics quality control metric for next-generation sequencing experiments in the clinical context

  2019cites this paper
• Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes

  2018cites this paper